S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:KURA

Kura Oncology News Headlines

$12.39
-1.13 (-8.36%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.39
$13.56
50-Day Range
$12.39
$21.00
52-Week Range
$12.32
$43.00
Volume
922,039 shs
Average Volume
884,720 shs
Market Capitalization
$824.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.58

Media Mentions By Week



Kura Oncology Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KURA
News Sentiment

0.26

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KURA Articles
This Week

5

1

KURA Articles
Average Week

Get Kura Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter.

Kura Oncology (NASDAQ:KURA) News Headlines Today

SourceHeadline
MarketBeat logoKura Oncology (NASDAQ:KURA) Shares Gap Down to $13.35
americanbankingnews.com - December 2 at 11:10 AM
MarketBeat logoKura Oncology, Inc. (NASDAQ:KURA) Sees Large Drop in Short Interest
americanbankingnews.com - November 30 at 9:18 AM
MarketBeat logoKura Oncology (NASDAQ:KURA) Earns "Buy" Rating from JMP Securities
americanbankingnews.com - November 29 at 1:16 PM
MarketBeat logoCredit Suisse Group Lowers Kura Oncology (NASDAQ:KURA) Price Target to $21.00
americanbankingnews.com - November 26 at 8:30 AM
benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kura Oncology, Inc. - KURA
benzinga.com - November 24 at 9:24 PM
finance.yahoo.com logoBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Kura Oncology, Inc. (KURA) Investigation
finance.yahoo.com - November 24 at 7:05 PM
markets.businessinsider.com logoSee Why FDA Hit Red Light On Kura's Early-Stage Leukemia Trial
markets.businessinsider.com - November 24 at 2:05 PM
finance.yahoo.com logoFDA Slams Kura Oncology With A Clinical Hold — And Investors Slam Its Stock
finance.yahoo.com - November 24 at 2:05 PM
finance.yahoo.com logoWhy Kura Oncology Stock Is Sliding Today
finance.yahoo.com - November 24 at 2:05 PM
MarketBeat logoKura Oncology (NASDAQ:KURA) Price Target Cut to $32.00
americanbankingnews.com - November 24 at 11:26 AM
MarketBeat logoKura Oncology (NASDAQ:KURA) Hits New 1-Year Low at $11.90
americanbankingnews.com - November 24 at 10:28 AM
marketwatch.com logoKura Oncology Shares Fall Amid Clinical Hold in Trial
marketwatch.com - November 24 at 8:57 AM
finance.yahoo.com logoKura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
finance.yahoo.com - November 24 at 8:57 AM
finance.yahoo.com logoKura Oncology, inc (KURA) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 5 at 5:59 PM
finance.yahoo.com logoKura Oncology Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 4 at 4:18 PM
finance.yahoo.com logoKura Oncology to Participate in Credit Suisse Healthcare Conference
finance.yahoo.com - November 2 at 12:00 PM
finance.yahoo.com logoKura Oncology to Report Third Quarter 2021 Financial Results
finance.yahoo.com - October 28 at 12:08 PM
nasdaq.com logoKura Oncology is Now Oversold (KURA)
nasdaq.com - October 27 at 9:06 PM
finance.yahoo.com logoAs Teresa Bair begins new role with Kura Oncology, she isn't cutting ties with Buffalo
finance.yahoo.com - October 19 at 2:36 PM
finance.yahoo.com logoKura Oncology Appoints Teresa Bair as Chief Legal Officer
finance.yahoo.com - October 18 at 8:31 AM
finance.yahoo.com logoKura Oncology Appoints Teresa Bair as Chief Legal Officer
finance.yahoo.com - October 18 at 8:31 AM
finance.yahoo.com logoCTI BioPharma Announces Appointment of Diane Parks to Its Board of Directors
finance.yahoo.com - August 24 at 8:23 AM
nasdaq.com logoKura Oncology Enters Oversold Territory (KURA)
nasdaq.com - August 10 at 10:34 PM
finance.yahoo.com logoWe Think Kura Oncology (NASDAQ:KURA) Can Afford To Drive Business Growth
finance.yahoo.com - August 9 at 10:16 AM
finance.yahoo.com logoKura Oncology, inc (KURA) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 6 at 5:51 PM
stocknews.com logo2 Biotech Wall Street Predicts Will More Than Double
stocknews.com - August 6 at 1:46 PM
finance.yahoo.com logoKura Oncology Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 5 at 8:05 PM
finance.yahoo.com logoKura Oncology Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 5 at 8:05 PM
finance.yahoo.com logoKura Oncology to Participate in Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 4 at 8:13 AM
finance.yahoo.com logoKura Oncology to Report Second Quarter 2021 Financial Results
finance.yahoo.com - July 29 at 5:43 PM
nasdaq.com logoKura Oncology, Inc. Common Stock (KURA)
nasdaq.com - July 16 at 6:47 PM
nasdaq.com logoFirst Week of September 17th Options Trading For Kura Oncology
nasdaq.com - July 16 at 6:47 PM
msn.com logoBRIEF-Kura Oncology Announces Clinical Collaboration To Evaluate Tipifarnib In Combination With Alpelisib In Head And Neck Squamous Cell Carcinoma
msn.com - July 6 at 9:40 AM
finance.yahoo.com logoKura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma
finance.yahoo.com - July 6 at 9:40 AM
msn.com logoBRIEF-Kura Oncology Doses First Patient In Phase 1B Expansion Cohorts With Menin Inhibitor Ko-539
msn.com - June 26 at 12:31 PM
finance.yahoo.com logoKura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO-539
finance.yahoo.com - June 24 at 12:41 PM
in.finance.yahoo.com logoIntellia Therapeutics Names James Basta, J.D., as Executive Vice President, General Counsel and Corporate Secretary
in.finance.yahoo.com - June 24 at 7:41 AM
finance.yahoo.com logoKura Oncology to Participate in JMP Securities Life Sciences Conference
finance.yahoo.com - June 10 at 8:53 AM
ca.finance.yahoo.com logoKura Oncology Appoints Carol Schafer to Board of Directors
ca.finance.yahoo.com - June 4 at 8:42 AM
finance.yahoo.com logoKura Oncology Appoints Carol Schafer to Board of Directors
finance.yahoo.com - June 4 at 8:42 AM
finance.yahoo.com logoKura Oncology to Participate in Cowen Virtual Oncology Innovation Summit
finance.yahoo.com - May 13 at 7:51 AM
finance.yahoo.com logoKura Oncology, Inc. (KURA) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 7 at 3:09 PM
finance.yahoo.com logoKura Oncology Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 6 at 6:08 PM
finance.yahoo.com logoKura Oncology to Report First Quarter 2021 Financial Results
finance.yahoo.com - April 29 at 9:02 AM
nasdaq.com logoKURA Crosses Above Key Moving Average Level
nasdaq.com - April 1 at 2:47 PM
finance.yahoo.com logoIs KURA Stock A Buy or Sell?
finance.yahoo.com - March 29 at 6:06 PM
finance.yahoo.com logoKura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical Oncology
finance.yahoo.com - March 22 at 7:13 PM
nasdaq.com logoKURA Makes Notable Cross Below Critical Moving Average
nasdaq.com - February 25 at 10:55 PM
nasdaq.com logoRSI Alert: Kura Oncology (KURA) Now Oversold
nasdaq.com - February 25 at 5:54 PM
benzinga.com logoHC Wainwright & Co. Maintains Buy on Kura Oncology, Lowers Price Target to $43
benzinga.com - February 24 at 9:53 PM
Get Kura Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.